Metraipolis › archive › dc_368a007e51fc
Ocrelizumab-Induced Brain Volume Dynamics in Relapsing-Remitting Multiple Sclerosis — Europe PMC PMID:42356446
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42356446
- DOI
- 10.3390/ph19060827
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T07:51:13.693Z
- SHA-256 of the archived text
31110a31f0f55a31c896abe06fd3482f7a93b1915ea215729d4b297fbf7542dc- Stable URL of this page
https://metraipolis.com/documento/dc_368a007e51fc
How to cite
Ocrelizumab-Induced Brain Volume Dynamics in Relapsing-Remitting Multiple Sclerosis — Europe PMC PMID:42356446 — Europe PMC (en), https://europepmc.org/article/MED/42356446 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_368a007e51fc (Metraipolis archive dc_368a007e51fc, sha256 31110a31f0f55a31c896abe06fd3482f7a93b1915ea215729d4b297fbf7542dc)
BibTeX
@misc{dc368a007e51fc,
title = {Ocrelizumab-Induced Brain Volume Dynamics in Relapsing-Remitting Multiple Sclerosis — Europe PMC PMID:42356446},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42356446},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_368a007e51fc; sha256 31110a31f0f55a31c896abe06fd3482f7a93b1915ea215729d4b297fbf7542dc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42356446. Agents can read the archived copy with the MCP tool read_document.